315 related articles for article (PubMed ID: 22162201)
1. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.
Delgado-Calle J; Sañudo C; Bolado A; Fernández AF; Arozamena J; Pascual-Carra MA; Rodriguez-Rey JC; Fraga MF; Bonewald L; Riancho JA
J Bone Miner Res; 2012 Apr; 27(4):926-37. PubMed ID: 22162201
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of alkaline phosphatase in human cells of the osteoblastic lineage.
Delgado-Calle J; Sañudo C; Sánchez-Verde L; García-Renedo RJ; Arozamena J; Riancho JA
Bone; 2011 Oct; 49(4):830-8. PubMed ID: 21700004
[TBL] [Abstract][Full Text] [Related]
3. Role of BMPs in the regulation of sclerostin as revealed by an epigenetic modifier of human bone cells.
Delgado-Calle J; Arozamena J; Pérez-López J; Bolado-Carrancio A; Sañudo C; Agudo G; de la Vega R; Alonso MA; Rodríguez-Rey JC; Riancho JA
Mol Cell Endocrinol; 2013 Apr; 369(1-2):27-34. PubMed ID: 23415712
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter.
Papathanasiou I; Kostopoulou F; Malizos KN; Tsezou A
Arthritis Res Ther; 2015 Jun; 17(1):160. PubMed ID: 26071314
[TBL] [Abstract][Full Text] [Related]
5. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells.
Hantusch B; Kalt R; Krieger S; Puri C; Kerjaschki D
BMC Mol Biol; 2007 Mar; 8():20. PubMed ID: 17343736
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
Vincent C; Findlay DM; Welldon KJ; Wijenayaka AR; Zheng TS; Haynes DR; Fazzalari NL; Evdokiou A; Atkins GJ
J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
[TBL] [Abstract][Full Text] [Related]
8. 1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion.
Wijenayaka AR; Yang D; Prideaux M; Ito N; Kogawa M; Anderson PH; Morris HA; Solomon LB; Loots GG; Findlay DM; Atkins GJ
Mol Cell Endocrinol; 2015 Sep; 413():157-67. PubMed ID: 26112182
[TBL] [Abstract][Full Text] [Related]
9. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin expression is induced by BMPs in human Saos-2 osteosarcoma cells but not via direct effects on the sclerostin gene promoter or ECR5 element.
Yu L; van der Valk M; Cao J; Han CY; Juan T; Bass MB; Deshpande C; Damore MA; Stanton R; Babij P
Bone; 2011 Dec; 49(6):1131-40. PubMed ID: 21890009
[TBL] [Abstract][Full Text] [Related]
11. Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts.
Sutherland MK; Geoghegan JC; Yu C; Winkler DG; Latham JA
Bone; 2004 Aug; 35(2):448-54. PubMed ID: 15268896
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation.
Sutherland MK; Geoghegan JC; Yu C; Turcott E; Skonier JE; Winkler DG; Latham JA
Bone; 2004 Oct; 35(4):828-35. PubMed ID: 15454089
[TBL] [Abstract][Full Text] [Related]
13. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.
Winkler DG; Sutherland MK; Geoghegan JC; Yu C; Hayes T; Skonier JE; Shpektor D; Jonas M; Kovacevich BR; Staehling-Hampton K; Appleby M; Brunkow ME; Latham JA
EMBO J; 2003 Dec; 22(23):6267-76. PubMed ID: 14633986
[TBL] [Abstract][Full Text] [Related]
14. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.
Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL
Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646
[TBL] [Abstract][Full Text] [Related]
15. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
16. Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H
J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759
[TBL] [Abstract][Full Text] [Related]
17. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
[TBL] [Abstract][Full Text] [Related]
18. Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts.
Villagra A; Gutiérrez J; Paredes R; Sierra J; Puchi M; Imschenetzky M; Wijnen Av Av; Lian J; Stein G; Stein J; Montecino M
J Cell Biochem; 2002; 85(1):112-22. PubMed ID: 11891855
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-induced up-regulation of TLR2 expression in human endothelial cells is independent of differential methylation in the TLR2 promoter CpG island.
Diesel B; Ripoche N; Risch RT; Tierling S; Walter J; Kiemer AK
Innate Immun; 2012 Feb; 18(1):112-23. PubMed ID: 21768203
[TBL] [Abstract][Full Text] [Related]
20. Does osteocytic SOST suppression mediate PTH bone anabolism?
Kramer I; Keller H; Leupin O; Kneissel M
Trends Endocrinol Metab; 2010 Apr; 21(4):237-44. PubMed ID: 20074973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
